MedPath

The efficacy and feasibility study of the Group Cognitive Behavioral Therapy program for Irritable Bowel Syndrome:open label pilot study

Not Applicable
Conditions
Irritable bowel syndrome
Registration Number
JPRN-UMIN000028702
Lead Sponsor
Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1.Person in whom organic disease is suggested by the presence of warning symptoms** 2.Those who can not understand Japanese 3.Persons suffering from sever anxiety disorders and depression or with suicidal ideation (diagnose by PHQ-9) 4.Any other person whom the principal investigator has determined to be unsuitable as a participant of the study **Warning symptoms list 1.Symptoms which first appeared after 50 years of age 2.Any rectal bleeding that has not undergone sufficient medical investigation (excluding that caused by known hemorrhoids) 3.Diarrhea predominant IBS in which no colonoscopy investigation has been conducted 4.Unexplained weight loss without a change in eating habits 5.Nocturnal symptoms sufficient to cause insomnia 6.The presence of warning symptoms (anemia, inflammatory reactions or fecal occult blood) 7.A medical history that makes evaluation of this study difficult. (Past and present) 8.Persons with a family history of colon cancer in a first or second degree relative (grandparents, parents, siblings or children)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath